NANCY UHLAND: Open Payments
NPI 1871918805 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 3 payments from 3 companies in 2025. Trend: 2023 $404 · 2024 $270 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $123 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
Products named: Vanrafia, ULTOMIRIS, Ozempic.
Industry payments across NY — which companies pay providers there.
